OX Fina

Emrify is launching a decentralized Personal Health Record platform on top of the Ethereum public blockchain to deliver trusted health information to the right hands at the right time anywhere in the world. With years of building consumer engagement mobile apps, Emrify is laser focused on collecting and locking up data for each person for complete ownership and control to freely share their data. Our top priority is to create attractive cryptoeconomics models to incentivize health data sharing for all parties. With strategic US partnerships with hospitals and doctors, Emrify is building on top of established prototypes to accelerate the launch of production interfaces to firmly establish the Utility Token in healthcare.

This exchange allows transmission of encrypted and secure documentation, restricting access to third parties and offering access management to these creditable transfers, through an auditable, verifable and secure P2P transaction. These transmissions will be made through a distributed network of nodes located in the main European DPCs, guaranteeing 24x7 availability of information as well as protection against information loss thanks to the redundancy of our distributed network.

Cure WorldCosplay is the world’s largest Cosplay platform, supporting 12 languages where more than 720,000 members from more than 180 countries post their quality works - 6.5 million images and counting. Our official social media accounts are followed by more than 430,000 people across Facebook, Twitter, and Weibo. We have a strong emphasis on providing community service which is characterized by self-sustainability and development. Cosplayers have various motivations for their activity, some Cosplayer want to become professional, others want more fans, and yet others are looking to share their work with groups. Photographers and Props Makers working closely with Cosplayers also have some influence on the increasing diversity of motivations. COT will be used as a payment currency within the Cure WorldCosplay ecosystem, helping cosplayers without access to other online payment methods to be tipped for their services. Using the Cure Protocol, players will also be able to create and distribute their own personalised coin. This unique feature will bring power back to cosplayers, enabling them to monetize themselves as these coins can be used to tip players as well as purchase merchandise or event tickets. Player Coins will provide an accessible platform for cosplayers to promote their identity to the continuously growing 720,000 member-base of Cure WorldCosplay, as they will be directly attainable by fans. These coins will also allow cosplayers to develop deeper relationships with their communities, as users will be able to explicitly show their support while also gamifying their experience.

The first Cross-Chain Interoperable DeFi Ecosystem, built natively on Avalanche The ActaFi Ecosystem brings a complete DeFi suite that incentivises user-base growth and motivates the user activity, offering both DeFi products and features in a single ecosystem. Every interaction within the ActaFi Ecosystem is executed on-chain, by smart contracts.

Talao is the first Ethereum-based DAO for Talent, which introduces a unique way for users to own their data thanks to a secure digital vault storing their certificates on the blockchain. Talao provides a decentralized marketplace, governed by Talent, on which neither intermediaries nor commissions apply.

The Svandis ecosystem is driven by a community of users and researchers using powerful Svandis tools, analytics, and indicators for professional traders in need of real-time, actionable data and analyses. The Svandis community drives the rapid collection of verifiable data and information through a tokenized incentive system. The platform within the ecosystem provides leading financial research, analytical and visualisation tools for anyone actively involved in the space: short-term and swing traders, traditional holders, analysts, hedge funds, institutional investors, trading firms, and token sale contributors.